Molecule Shows Potential to Protect Neurons in Early Huntington’s Disease Study
Apr 22, 2016 07:00 am | Alisa Woods, PhD
A research report discusses the use of six versions of a new type of molecule, known as xyloketal B, for the treatment of Huntington’s disease. Scientists tested the six possible drugs in a worm model of Huntington’s disease, Caenorhabditis elegans. Results of the study, “Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates inCaenorhabditis elegans […]
The post Molecule Shows Potential to Protect Neurons in Early Huntington’s Disease Study appeared first on Huntington's Disease News.